Edgar Filing: AVIV REIT, INC.

Large Accelerated Filer

Accelerated Filer

Non-Accelerated Filer

þ (Do not check if a smaller reporting company)

Smaller reporting company

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended September 30, 2011

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from to

Commission file number 333-173824-103 (Aviv REIT, Inc.)

Commission file number 333-173824 (Aviv Healthcare Properties Limited Partnership)

AVIV REIT, INC.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

(Exact Name of Registrant as Specified in Its Charter)


Maryland (Aviv REIT, Inc.) Delaware (Aviv Healthcare Properties Limited Partnership)				27-3200673 (Aviv REIT, Inc.) 35-2249166 (Aviv Healthcare Properties Limited Partnership)
(State or Other Jurisdiction of Incorporation or Organization)				(I.R.S. Employer Identification No.)

303 W. Madison Street, Suite 2400 Chicago, Illinois				60606
(Address of Principal Executive Offices)				(Zip Code)

(312) 855-0930

(Registrant’s Telephone Number, Including Area Code)

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

As of November 14, 2011, Aviv REIT, Inc. had 262,278 shares of common stock outstanding.

As of November 14, 2011, Aviv Healthcare Properties Limited Partnership had 13,467,223 Class A Units, 4,523,145 Class B Units, 100 Class C Units, 8,050 Class D Units, 2,684,900 Class F Units and 262,278 Class G Units outstanding.

EXPLANATORY NOTE

This combined Form 10-Q is being filed separately by Aviv REIT, Inc. (“Aviv REIT”) and Aviv Healthcare Properties Limited Partnership (the “Partnership”). Unless the context requires otherwise or except as otherwise noted, as used herein the words “we,” “company,” “us” and “our” refer to Aviv REIT, Inc. and Subsidiaries and Aviv Healthcare Properties Limited Partnership and Subsidiaries, as the operations of the two aforementioned entities are materially comparable for the periods presented.

TABLE OF CONTENTS


	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
Aviv REIT, Inc. and Subsidiaries
Consolidated Balance Sheets as of September 30, 2011 and December 31, 2010 (unaudited)		1
Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2011 and 2010 (unaudited)		2
Consolidated Statements of Changes in Equity for the Nine Months Ended September 30, 2011 (unaudited)		3
Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2011 and 2010 (unaudited)		4
Notes to Consolidated Financial Statements (unaudited)		5
Aviv Healthcare Properties Limited Partnership and Subsidiaries
Consolidated Balance Sheets as of September 30, 2011 and December 31, 2010 (unaudited)		20
Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2011 and 2010 (unaudited)		21
Consolidated Statements of Changes in Equity for the Nine Months Ended September 30, 2011 (unaudited)		22
Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2011 and 2010 (unaudited)		23
Notes to Consolidated Financial Statements (unaudited)		24
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		47
Item 3. Quantitative and Qualitative Disclosures about Market Risk		65
Item 4. Controls and Procedures		65
PART II. OTHER INFORMATION		66
Item 1. Legal Proceedings		66
Item 5. Other Information		66
Item 6. Exhibits		66
SIGNATURES		67

AVIV REIT, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited)


	September 30, 2011			December 31, 2010
Assets
Cash and cash equivalents	$	6,264,886		$	13,029,474
Deferred rent receivable		28,873,295			30,660,773
Tenant receivables, net		6,090,209			1,168,842
Rental properties and financing leases, at cost:
Land		90,882,968			76,466,020
Buildings and improvements		705,696,951			615,806,273
Assets under direct financing leases		10,881,228			10,777,184

		807,461,147			703,049,477
Less accumulated depreciation		(91,252,681	)		(75,948,944	)

Net rental properties		716,208,466			627,100,533
Deferred finance costs, net		13,648,381			9,957,636
Loan receivables, net		30,868,334			36,610,638
Other assets		5,629,414			12,872,323

Total assets	$	807,582,985		$	731,400,219

Liabilities and equity
Accounts payable and accrued expenses	$	10,090,892		$	6,012,809
Tenant security and escrow deposits		14,218,676			13,658,384
Other liabilities		31,584,569			25,996,492
Mortgage and other notes payable		525,486,808			440,575,916

Total liabilities		581,380,945			486,243,601
Equity:
Stockholders' equity
Common stock (par value $0.01; 235,898 and 227,003 shares outstanding, respectively)		2,359			2,270
Additional paid-in-capital		234,775,166			223,838,999
Accumulated deficit		(15,219,201	)		(2,261,839	)
Accumulated other comprehensive (loss) income		(1,669,782	)		2,188,155

Stockholders' equity		217,888,542			223,767,585
Noncontrolling interests		8,313,498			21,389,033

Total equity		226,202,040			245,156,618

Total liabilities and equity	$	807,582,985		$	731,400,219

See accompanying notes to consolidated financial statements.

AVIV REIT, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Revenues
Rental income	$	20,979,359		$	21,354,972		$	64,782,196		$	63,776,959
Tenant recoveries		1,800,900			1,640,285			5,325,960			4,851,521
Interest on loans to lessees—capital expenditures		266,506			183,613			957,608			909,186
Interest on loans to lessees—working capital and capital lease		970,316			1,144,301			2,960,338			2,937,698

Total revenues		24,017,081			24,323,171			74,026,102			72,475,364
Expenses
Rent and other operating expenses		228,499			199,500			621,304			484,476
General and administrative		5,974,461			2,376,911			12,986,000			6,486,367
Real estate taxes		1,771,520			1,558,495			5,473,975			4,870,994
Depreciation		5,322,918			4,451,210			15,303,737			13,248,400
Loss on impairment		858,916			96,000			858,916			96,000

Total expenses		14,156,314			8,682,116			35,243,932			25,186,237

Operating income		9,860,767			15,641,055			38,782,170			47,289,127
Other income and expenses:
Interest and other income		7,276			(14,116	)		840,144			41,816
Interest expense		(9,311,128	)		(5,211,327	)		(26,226,779	)		(16,123,723	)
Change in fair value of derivatives		—			489,312			—			2,931,309
Amortization of deferred financing costs		(667,406	)		(194,324	)		(1,996,845	)		(472,914	)
Earnout accretion		(100,088	)		—			(166,814	)		—
Gain on sale of assets		—			581,734			—			581,734
Loss on extinguishment of debt		—			(2,285,028	)		(3,806,513	)		(2,285,028	)

Total other income and expenses		(10,071,346	)		(6,633,749	)		(31,356,807	)		(15,326,806	)

Net (loss) income		(210,579	)		9,007,306			7,425,363			31,962,321
Distributions and accretion on Class E Preferred Units		—			(9,353,806	)		—			(17,371,893	)
Net loss (income) allocable to common units of Partnership/noncontrolling interests		96,030			960,162			(3,386,174	)		(13,976,766	)

Net (loss) income allocable to stockholders	$	(114,549	)	$	613,662		$	4,039,189		$	613,662

Net (loss) income	$	(210,579	)				$	7,425,363
Unrealized loss on derivative instrument		(4,086,047	)					(7,164,043	)

Total comprehensive (loss) income	$	(4,296,626	)				$	261,320

Net (loss) income allocable to stockholders	$	(114,549	)				$	4,039,189
Unrealized loss on derivative instrument, net of noncontrolling interest portion of $1,863,352 and $3,306,106, respectively		(2,222,695	)					(3,857,937	)

Total comprehensive (loss) income allocable to stockholders	$	(2,337,244	)				$	181,252

See accompanying notes to consolidated financial statements.

AVIV REIT, INC. AND SUBSIDIARIES

Consolidated Statement of Changes in Equity

Nine Months Ended September 30, 2011 (unaudited)


	Common Stock				Additional Paid-In- Capital		Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Total Stockholders' Equity			Noncontrolling Interests			Total Equity
	Shares		Amount		Additional Paid-In- Capital		Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Total Stockholders' Equity			Noncontrolling Interests			Total Equity
Balance at January 1, 2011		227,003	$	2,270	$	223,838,999	$	(2,261,839	)	$	2,188,155		$	223,767,585		$	21,389,033		$	245,156,618
Non-cash stock (unit)-based compensation		—		—		936,256		—			—			936,256			662,459			1,598,715
Distributions to partners		—		—		—		—			—			—			(14,237,819	)		(14,237,819	)
Capital contributions		8,895		89		9,999,911		—			—			10,000,000			419,757			10,419,757
Unrealized loss on derivative instruments		—		—		—		—			(3,857,937	)		(3,857,937	)		(3,306,106	)		(7,164,043	)
Dividends to stockholders		—		—		—		(16,996,551	)		—			(16,996,551	)		—			(16,996,551	)
Net inco-me		—		—		—		4,039,189			—			4,039,189			3,386,174			7,425,363

Balance at September 30, 2011		235,898	$	2,359	$	234,775,166	$	(15,219,201	)	$	(1,669,782	)	$	217,888,542		$	8,313,498		$	226,202,040

See accompanying notes to consolidated financial statements.

AVIV REIT, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited)


	Nine Months Ended September 30,
	2011			2010
Operating activities
Net income	$	7,425,363		$	31,962,321
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		15,303,737			13,248,400
Amortization		1,996,845			472,914
Change in fair value of derivatives		—			(2,931,309	)
Deferred rental loss (income), net		1,586,497			(2,600,415	)
Rental income from intangible amortization, net		(1,044,431	)		(3,318,913	)
Non-cash stock (unit)-based compensation		1,598,715			345,101
Gain on sale of assets		—			(581,734	)
Non-cash loss on extinguishment of debt		3,806,513			1,437,233
Loss on impairment of assets		858,916			96,000
Reserve for uncollectible loan receivables		1,250,113			—
Accretion of earn-out provision for previously acquired rental properties		166,814			—
Changes in assets and liabilities:
Tenant receivables		(6,685,920	)		557,018
Other assets		2,070,268			(309,666	)
Accounts payable and accrued expenses		95,433			(1,080,771	)
Tenant security deposits and other liabilities		3,048,863			40,327

Net cash provided by operating activities		31,477,726			37,336,506

Investing activities
Purchase of rental properties		(80,719,101	)		(8,380,000	)
Sales of rental properties		—			3,988,927
Capital improvements and other developments		(17,300,401	)		(5,863,863	)
Payment of earn-out provision for previously acquired rental properties		—			(9,600,731	)
Loan receivables received from (funded to) others, net		6,256,744			(5,637,247	)

Net cash used in investing activities		(91,762,758	)		(25,492,914	)

Financing activities
Borrowings of debt		328,802,912			405,000,000
Repayment of debt		(243,892,020	)		(480,309,036	)
Payment of financing costs		(9,429,792	)		(10,405,360	)
Payment for swap termination		—			(3,380,160	)
Capital contributions		10,419,757			223,772,055
Redemption of Class E Preferred Units		—			(92,001,451	)
Redemption of Class F Units		—			(23,602,649	)
Cash distributions to partners		(14,838,568	)		(33,003,335	)
Cash dividends to stockholders		(17,541,845	)		—

Net cash provided by (used in) financing activities		53,520,444			(13,929,936	)

Net decrease in cash and cash equivalents		(6,764,588	)		(2,086,344	)
Cash and cash equivalents:
Beginning of period		13,029,474			15,542,507

End of period	$	6,264,886		$	13,456,163

Supplemental cash flow information
Cash paid for interest	$	25,080,857		$	16,644,364

Supplemental disclosure of noncash activity
Accrued dividends payable to stockholders	$	5,547,639		$	—
Accrued distributions payable to partners	$	4,646,091		$	3,106,549
Earn-out accrual and addition to rental properties	$	3,332,745		$	—
Write-off of deferred rent receivable	$	6,785,132		$	2,233,768
Write-off of in-place lease intangibles, net	$	35,536		$	1,956,499
Write-off of deferred financing costs, net	$	3,806,513		$	1,235,969
Write-off debt discount	$	—		$	202,307

See accompanying notes to consolidated financial statements.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

1. Description of Operations and Formation

Aviv REIT, Inc., a Maryland corporation, and Subsidiaries (the REIT) is the sole general partner of Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and Subsidiaries (the Partnership). The Partnership is a majority owned subsidiary that owns all of the real estate properties. In these footnotes, the Company refers generically to Aviv REIT, Inc., the Partnership, and their subsidiaries. The Partnership was formed in 2005 and directly or indirectly owned or leased 200 properties, principally skilled nursing facilities, across the United States at September 30, 2011. The Company generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for tenants to pay the Company an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the tenants. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of real estate properties. The Company manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting.

The Partnership is the general partner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership, and Aviv Healthcare Capital Corporation, a Delaware company. The Operating Partnership has five wholly owned subsidiaries: Aviv Financing I, LLC (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, LLC (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, LLC (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, LLC (Aviv Financing IV), a Delaware limited liability company; and Aviv Financing V, LLC (Aviv Financing V), a Delaware limited liability company.

On September 17, 2010, the predecessor to the Partnership entered into an agreement (the Merger Agreement), by and among the REIT, Aviv Healthcare Merger Sub LP, a Delaware limited partnership of which the REIT is the general partner (Merger Sub), Aviv Healthcare Merger Sub Partner LLC, a Delaware limited liability company and a wholly owned subsidiary of the REIT, and the predecessor to the Partnership. Pursuant to the Merger Agreement, the predecessor to the Partnership merged (the Merger) with and into Merger Sub, with Merger Sub continuing as the surviving entity with the identical name (the Surviving Partnership). Following the Merger, the REIT remains as the sole general partner of the Surviving Partnership and the Surviving Partnership, as the successor to the predecessor to the Partnership, became the general partner of the Operating Partnership. All of the business, assets and operations will continue to be held by the Operating Partnership and its subsidiaries. The REIT’s equity interest in the Surviving Partnership will be linked to future investments in the REIT, such that future equity issuances by the REIT (pursuant to the Stockholders Agreement, the REIT’s management incentive plan or otherwise as agreed between the parties) will result in a corresponding increase in the REIT’s equity interest in the Surviving Partnership. The REIT is authorized to issue 2 million shares of common stock (par value $0.01) and 1,000 shares of preferred stock (par value $1,000). At September 30, 2011, there were 235,898 shares of common stock and 125 shares of preferred stock outstanding. An additional 26,380 shares of common stock were issued by the REIT on October 28, 2011 concurrent with a $30 million equity contribution by the REIT’s stockholders. Dividends on each outstanding share of preferred stock accrue on a daily basis at the rate of 12.5% per annum of the sum of $1,000 plus all accumulated and unpaid dividends thereon which are in arrears. The REIT makes annual distributions on the preferred shares in the aggregate amount of $15,625 per year. With respect to the payment of dividends or other distributions and the distribution of the REIT’s assets upon dissolution, liquidation, or winding up, the preferred stock will be senior to all other classes and series of stock of the REIT. The preferred stock has not been shown separately in the consolidated balance sheets, is immaterial, and included in additional paid-in-capital.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

the Partnership in exchange for Class G Units in the Partnership. Periods prior to September 17, 2010 represent the results of operations and financial condition of the Partnership, as predecessor to the Company. An additional $10 million was contributed by the REIT’s stockholders on January 25, 2011. Subsequently, an additional $30 million was contributed by the REIT’s stockholders on October 28, 2011.

The operating results of the Partnership are allocated based upon the respective economic interests therein. As of September 30, 2011, the REIT owned 54.4% of the Partnership. On October 28, 2011, the REIT’s stockholders contributed $30 million to the REIT, which was further contributed to the Partnership, increasing the REIT ownership of the Partnership to 57.01%.

2. Summary of Significant Accounting Policies

Estimates

The preparation of the financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the REIT, the Partnership, the Operating Partnership, and all controlled subsidiaries. The Company considers itself to control an entity if it is the majority owner of and has voting control over such entity or the power to control a variable interest entity. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.

Quarterly Reporting

The accompanying unaudited financial statements and notes of the Company as of September 30, 2011 and for the three and nine months ended September 30, 2011 and 2010 have been prepared in accordance with GAAP for interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under GAAP have been condensed or omitted pursuant to such rules. In the opinion of management, all adjustments considered necessary for a fair presentation of the Company’s balance sheets, statements of operations, statement of changes in equity, and statements of cash flows have been included and are of a normal and recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the Company for the years ended December 31, 2010, 2009, and 2008. The consolidated statements of operations and cash flows for the three and nine months ended September 30, 2011 and 2010 are not necessarily indicative of full year results.

The balance sheet at December 31, 2010 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. For further information, including definitions of capitalized terms not defined herein, refer to the consolidated financial statements and footnotes thereto included in the Partnership’s Registration Statement on Form S-4 declared effective by the Securities and Exchange Commission on July 21, 2011.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

Rental Properties

The Company periodically assesses the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of the Company’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis. As part of the impairment evaluation during 2011, a building in Medford, MA was impaired for $858,916 to reflect the difference between the book value and the estimated selling price less costs to dispose (Level 3).

Revenue Recognition

Rental income is recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to deferred rent receivable. Income recognized from this policy is titled deferred rental income. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and are reflected as tenant recoveries on the consolidated statements of operations.

Below is a summary of the components of rental income for the respective periods:


	Three Months Ended September 30,					Nine Months Ended September 30,
	2011			2010		2011			2010
Cash rental income	$	22,541,964		$	18,876,220	$	65,324,262		$	57,857,631
Deferred rental (loss) income		(1,882,643	)		1,423,137		(1,586,497	)		2,600,415
Rental income from intangible amortization		320,038			1,055,615		1,044,431			3,318,913

Total rental income	$	20,979,359		$	21,354,972	$	64,782,196		$	63,776,959

During the three and nine months ended September 30, 2011 and 2010, deferred rental (loss) income includes a write-off (expense) of deferred rent receivable of $3,504,562, $6,785,936, $0 and $2,233,768, respectively, due to the early termination of leases and replacement of operators.

Lease Accounting

The Company, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Company’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease. Such accretion was $33,832, $104,044, $35,100 and $107,614 for the three and nine months ended September 30, 2011 and 2010, respectively.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

All of the Company’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

Loan Receivables

Loan receivables consist of capital improvement loans to tenants and working capital loans to operators. Loan receivables are carried at their principal amount outstanding. Management periodically evaluates outstanding loans and notes receivable for collectability. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. As of September 30, 2011 and December 31, 2010, loan receivable reserves amounted to $2,000,113 and $750,000, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates.

Stock-Based Compensation

The Company follows ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their grant date fair values. On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. A pro-rata allocation of non-cash stock-based compensation expense is made to the Company and noncontrolling interests for awards granted under the Plan. The Plan’s non-cash stock-based compensation expense by the Company through September 30, 2011 is summarized in Footnote 9.

Fair Value of Financial Instruments

ASC 820, Fair Value Measurements and Disclosures (ASC 820), establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:

•

Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or;

•

Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and

•

Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The Company’s interest rate swaps are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

similar maturities and collateral securing the indebtedness. The Company had outstanding loan receivables with a carrying value of $30.9 million and $36.6 million as of September 30, 2011 and December 31, 2010, respectively. The fair values of loan receivables as of September 30, 2011 and as of December 31, 2010 approximate its carrying value based upon interest rates available to the Company on similar borrowings.

Derivative Instruments

The Company has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Company’s derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for or the Company does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statement of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income. All of the changes in the fair market values of our derivative instruments are recorded in the consolidated statements of operations for our interest rate swaps that were terminated in September 2010. In November 2010, we entered into two interest rate swaps and account for changes in fair value of such hedges through accumulated other comprehensive (loss) income in equity in our financial statements via hedge accounting.

Income Taxes

For federal income tax purposes, the Company elected, with the filing of its initial 1120 REIT, U.S. Income Tax Return for Real Estate Investment Trusts, to be taxed as a Real Estate Investment Trust (REIT) effective at the time of the Merger. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. The Company currently intends to comply with these requirements and maintain REIT status. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes at regular corporate rates (including any applicable alternative minimum tax) and may not elect REIT status for four subsequent years. However, the Company may still be subject to federal excise tax. In addition, the Company may be subject to certain state and local income and franchise taxes. Historically, the Company and its predecessor have generally only incurred certain state and local income and franchise taxes, but these amounts were immaterial in each of the periods presented. Prior to the Merger, the Partnership was a limited partnership and the consolidated operating results were included in the income tax returns of the individual partners. No uncertain income tax positions exist as of September 30, 2011 or December 31, 2010.

Business Combinations

The Company applies ASC 805, Business Combinations (ASC 805), in determining how to account for and identify business combinations while allocating fair value to tangible and identified intangible assets acquired and liabilities assumed using market comparables and historical operating results (Level 3). Acquisition related costs are expensed as incurred. Prior to the Merger on September 17, 2010, Aviv Asset Management, L.L.C. (AAM) was a non-consolidated management company to the Partnership based on the application of appropriate accounting guidance (as discussed in Footnote 10). Upon the Merger, AAM became a consolidated entity of the Company and is presented as such for all periods included herein with all periods shown at historical cost (carryover basis with no adjustments to fair value). This treatment is in accordance with ASC 805 due to the fact that AAM was under common control prior and subsequent to the Merger.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s consolidated financial position or results of operations.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

3. Rental Property Activity

The Company had the following rental property activity during the nine months ended September 30, 2011 as described below:

•

In January 2011, Aviv Financing I acquired a property in Kansas from an unrelated third party for a purchase price of $3,045,000. The Company financed this purchase through cash and borrowings of $2,131,000 under the Acquisition Credit Line (see Footnote 7).

•

In March 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of approximately $2,200,000. The Company financed this purchase through cash.

•

In March 2011, Aviv Financing II acquired a property in Ohio from an unrelated third party for a purchase price of approximately $9,581,000. The Company financed this purchase through cash.

•

In March 2011, Aviv Financing II acquired a property in Florida from an unrelated third party for a purchase price of approximately $10,000,000. The Company financed this purchase through borrowings of $10,200,000 under the Revolver (see Footnote 7).

•

In April 2011, Aviv Financing II acquired three properties in Ohio from an unrelated third party for a purchase price of $9,250,000. The Company financed this purchase through cash.

•

In April 2011, Aviv Financing II acquired a property in Kansas from an unrelated third party for a purchase price of $1,300,000. The Company financed this purchase through cash.

•

In April 2011, Aviv Financing II acquired a property in Texas from an unrelated third party for a purchase price of $2,093,000. The Company financed this purchase through cash.

•

In April 2011, Aviv Financing II acquired three properties in Texas from an unrelated third party for a purchase price of $8,707,000. The Company financed this purchase through cash.

•

In May 2011, Aviv Financing II acquired three properties in Kansas from an unrelated third party for a purchase price of $2,273,000. The Company financed this purchase through cash.

•

In May 2011, Aviv Financing II acquired a property in Missouri from an unrelated third party for a purchase price of $5,470,000. The Company financed this purchase through cash.

•

In May 2011, Aviv Financing II acquired a property in Connecticut from an unrelated third party for a purchase price of $12,000,000. In addition, as part of this acquisition, the Company recognized an approximate $3,333,000 addition to the purchase price as per the guidance within ASC 805 as it relates to an earn-out provision defined at closing (Level 3). The Company financed this purchase through cash.

•

In August 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of $6,100,000. The Company financed this purchase through borrowings under the Revolver (see Footnote 7).

•

In August 2011, Aviv Financing II acquired a property in Connecticut from an unrelated third party for a purchase price of $5,500,000. The Company financed this purchase through borrowings under the Revolver (see Footnote 7).

•

In September 2011, Aviv Financing I acquired a property in Ohio from an unrelated third party for a purchase price of $3,200,000. The Company financed this purchase through borrowings under the Revolver (see Footnote 7).

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

Related to the above business combinations, the Company incurred $984,000 of acquisition costs that are expensed in general and administrative expenses in the consolidated statements of operations. In accordance with ASC 805, the Company allocated the approximate net purchase price paid for these properties acquired in 2011 as follows:


Land	$	13,288,000
Buildings and improvements		67,431,000

Borrowings and available cash	$	80,719,000

The Company considers renewals on below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Company evaluates whether the stated renewal rate is below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the tenant, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.

4. Loan Receivables

The following summarizes the Company’s loan receivables at:


	September 30, 2011			December 31, 2010
Beginning balance, January 1, 2011 and 2010, respectively	$	36,610,638		$	28,970,129
New capital improvement loans issued		765,463			1,415,579
Working capital and other loans issued		6,846,377			14,705,259
Reserve for uncollectible loans		(1,250,113	)		(750,000	)
Loan write offs		(86,156	)		—
Loan amortization and repayments		(12,017,875	)		(7,730,329	)

	$	30,868,334		$	36,610,638

The Company’s reserve for uncollectible loan receivables balances at September 30, 2011 and December 31, 2010 was $2,000,113 and $750,000, respectively. The activity for the three and nine months ended September 30, 2011 consisted of additional reserves of $926,474 and $1,250,113, respectively.

During 2011 and 2010, the Company funded loans for both working capital and capital improvement purposes to various operators and tenants. All loans held by the Company accrue interest. The payments received from the operator or tenant cover both interest accrued as well as amortization of the principal balance due. Any payments received from the tenant or operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.

Interest income earned on loan receivables for the three and nine months ended September 30, 2011 and 2010 was $880,965, $2,853,722, $976,682 and $2,796,655, respectively.

5. Deferred Finance Costs

The following summarizes the Company’s deferred finance costs at:

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)


	September 30, 2011			December 31, 2010
Gross amount	$	15,790,721		$	10,567,931
Accumulated amortization		(2,142,340	)		(610,295	)

Net	$	13,648,381		$	9,957,636

Amortization of deferred financing costs is reported in the amortization expense line item in the consolidated statements of operations.

During the three and nine months ended September 30, 2011, the Company wrote-off deferred financing costs of $0 and $4,271,312, respectively with $0 and $464,799 of accumulated amortization associated with the Mortgage (see Footnote 7) pay down for a net recognition as loss on extinguishment of debt of $0 and $3,806,513, respectively.

6. In-Place Lease Intangibles

The following summarizes the Company’s in-place lease intangibles classified as part of other assets or other liabilities at:


	September 30, 2011						December 31, 2010
	Assets			Liabilities			Assets			Liabilities
Gross amount	$	7,460,119		$	24,363,147		$	8,393,488		$	25,798,147
Accumulated amortization		(3,193,933	)		(14,737,331	)		(3,049,093	)		(14,049,691	)

	$	4,266,186		$	9,625,816		$	5,344,395		$	11,748,456

Amortization expense for the in-place lease intangible assets for the three and nine months ended September 30, 2011 and 2010 was $161,142, $483,427, $199,628 and $621,232, respectively. Accretion for the in-place lease intangible liabilities for the three and nine months ended September 30, 2011 and 2010 was $516,566, $1,563,243, $523,339 and $1,983,647, respectively.

For both the three and nine months ended September 30, 2011, the Company wrote-off in-place lease intangible assets of $933,369 with accumulated amortization of $338,587, and in-place lease intangible liabilities of $1,435,000 with accumulated accretion of $875,603, for a net recognition of $35,385 in rental income from intangible amortization. These write-offs were in connection with the anticipated termination of leases that will be transitioned to new operators.

During the three and nine months ended September 30, 2010, the Company wrote-off in-place lease intangible assets of $265,000 and $2,943,000 with accumulated amortization of $215,020 and $1,531,253, and in-place lease intangible liabilities of $3,817,347 and $8,477,347 with accumulated accretion of $3,035,463 and $5,109,101, for a net recognition of $731,904 and $1,956,499 in rental income from intangible amortization, respectively. These write-offs were in connection with the anticipated termination of leases that were transitioned to new operators.

7. Mortgage and Other Notes Payable

The Company’s mortgage and other notes payable consisted of the following:


	September 30,		December 31,
	2011		2010
Mortgage (interest rates of 5.75% on September 30, 2011 and December 31, 2010, respectively)	$	197,859,139	$	402,794,111
Acquisition Credit Line (interest rates of 5.75% on September 30, 2011 and December 31, 2010, respectively)		—		28,677,230
Construction loan (interest rates of 5.95% on September 30, 2011 and December 31, 2010, respectively)		2,295,066		1,312,339
Revolver (interest rate of 6.50% on September 30, 2011)		15,000,000		—

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)


Acquisition loans (interest rates of 6.00% on September 30, 2011 and December 31, 2010, respectively)		7,712,418		7,792,236
Senior Notes (interest rate of 7.75% on September 30, 2011), inclusive of $2.6 million net premium balance		302,620,185		—

Total	$	525,486,808	$	440,575,916

Senior Notes

On February 4, 2011 and April 5, 2011, Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation (the Issuers) issued $200 million and $100 million of Senior Notes (the Senior Notes), respectively. The REIT is a guarantor of the Issuers’ Senior Notes. The Senior Notes are unsecured senior obligations of the Issuers and will mature on February 15, 2019. The Senior Notes bear interest at a rate of 7.75% per annum, payable semiannually to holders of record at the close of business on the February 1 or the August 1 immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011. A premium of $2.75 million was associated with the offering of the $100 million of Senior Notes on April 5, 2011. The premium will be amortized as an adjustment to the yield on the Senior Notes over their term. The Company used the proceeds, amongst other things, to pay down approximately $201.6 million on the Mortgage and the balance of $28.7 million on the Acquisition Credit Line.

Revolver

In conjunction with the Senior Notes issuance on February 4, 2011, the Company, under Aviv Financing IV, LLC, entered into a $25 million revolver with Bank of America (the Revolver). On each payment date, the Company pays interest only in arrears on any outstanding principal balance of the Revolver. The interest rate under the Company’s Revolver is generally based on LIBOR (subject to a floor of 1.0% and subject to the Company’s option to elect to use a prime base rate) plus a margin that is determined by the Company’s leverage ratio from time to time. As of September 30, 2011 the interest rates are based upon the base rate (3.25% at September 30, 2011) plus the applicable percentage based on the consolidated leverage ratio (3.25% at September 30, 2011). The base rate is the rate announced by Bank of America as the “prime rate”. Additionally, an unused fee equal to 0.5% per annum of the daily unused balance on the Revolver is due monthly. The Revolver commitment terminates in February 2014. The Revolver had an outstanding balance of $15,000,000 at September 30, 2011.

8. Partnership Equity and Incentive Program

Distributions to the Partnership’s partners are summarized as follows for the three months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011	$	1,683,430	$	809,605	$	1,599,295	$	—	$	—	$	553,761	$	5,547,638
2010	$	2,911,567	$	997,288	$	9,072,045	$	—	$	1,623,288	$	958,840	$	—

Distributions to the Partnership’s partners are summarized as follows for the nine months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011	$	5,050,290	$	2,702,588	$	4,823,658	$	—	$	—	$	1,661,283	$	16,996,392
2010	$	9,692,937	$	2,894,457	$	11,917,798	$	—	$	5,342,466	$	3,155,677	$	—

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

Weighted-average Units outstanding are summarized as follows for the three months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011		13,467,223		4,523,145		2		8,050		—		2,684,900		236,022
2010		13,467,223		4,523,145		2		7,250		6,440,260		5,241,948		—

Weighted-average Units outstanding are summarized as follows for the nine months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011		13,467,223		4,523,145		2		8,050		—		2,684,900		235,207
2010		13,467,223		4,523,145		2		7,403		7,142,888		4,990,412		—

The Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards can be settled in Class C Units or cash at the Company’s discretion at the settlement date of December 31, 2012. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for the three and nine months ended September 30, 2011 and 2010 was approximately $101,500, $304,500, $101,500 and $304,500, respectively.

As a result of the Merger on September 17, 2010, such incentive program was modified such that 40% of the previously granted award settled immediately on the Merger date with another 20% vesting and settling on December 31, 2010. The remaining 40% will vest equally on December 31, 2011 and December 31, 2012, and will settle in 2018, subject to the terms and conditions of the amended incentive program agreement. In accordance with ASC 718, Compensation – Stock Compensation (ASC 718), such incentive program will continue to be expensed through general and administrative expenses as non-cash compensation on the statements of operations through the ultimate vesting date of December 31, 2012.

9. Option Awards

On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction.

The following table represents the time based option awards activity for the nine months ended September 30, 2011.


	Nine months ended
	September 30, 2011
Outstanding at January 1, 2011		21,866
Granted		456
Exercised		—
Cancelled/Forfeited		—

Outstanding at March 31, 2011		22,322
Granted		—
Exercised		—
Cancelled/Forfeited		—

Outstanding at June 30, 2011		22,322
Granted		—
Exercised		—
Cancelled/Forfeited		—

Outstanding at September 30, 2011		22,322
Options exercisable at end of period		—

Weighted average fair value of options granted to date	$	109.37

Weighted average remaining contractual life (years)		8.97

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

The following table represents the time based option awards outstanding at September 30, 2011 as well as other Plan data:

Range of exercise

prices

Outstanding

Remaining Contractual
Life (Years)

Weighted Average
Exercise Price

$1,000 – $1,124

22,322

8.98

$1,004

The Company has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2011.


	2011 Grants
Dividend yield		9.16	%
Risk-free interest rate		2.72	%
Expected life		7.0 years
Estimated volatility		38.00	%
Weighted average exercise price	$	1,124.22
Weighted average fair value of options granted (per option)	$	149.09

The Company recorded non-cash compensation expenses of $329,889 and $936,256 for the three and nine months ended September 30, 2011, related to the time based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations, respectively.

At September 30, 2011, the total compensation cost related to outstanding, non-vested time based equity option awards that are expected to be recognized as compensation cost in the future aggregates to approximately $1,167,606.


For the period ended December 31,	Options
2011	$	168,963
2012		575,013
2013		304,499
2014		119,078
2015		53

Total	$	1,167,606

Dividend equivalent rights associated with the Plan amounted to $524,567 and $1,607,181 for the three and nine months ended September 30, 2011, and are included in general and administrative expense in the consolidated statements of operations, respectively. These dividend rights will be paid in four installments as the option vests.

10. Related Parties

Related party receivables and payables represent amounts due from/to various affiliates of the Company, including advances to members of the Company, amounts due to certain acquired companies and limited liability companies for transactions occurring prior to the formation of the Company, and various advances to entities controlled by affiliates of the Company’s management. An officer of the Company received a loan of $311,748, which has been paid off in full as of September 30, 2011.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

below. In addition, the Partnership reimbursed AAM for all reasonable and necessary out-of-pocket expenses incurred in AAM’s conduct of its business, including, but not limited to, travel, legal, appraisal, and brokerage fees, fees and expenses incurred in connection with the acquisition, disposition, or refinancing of any property, and reimbursement of compensation and benefits of the officers and employees of AAM. This agreement was terminated on September 17, 2010 when the Merger occurred, effectively consolidating AAM into the Company, and eliminating the necessity for reimbursement.

On October 16, 2007, the Company legally acquired AAM through a Manager Contribution and Exchange Agreement dated October 16, 2007 (the Contribution Agreement). As stipulated in the Contribution Agreement and the Second Amended and Restated Agreement of Limited Partnership on October 16, 2007 (Partnership Agreement), the Company issued a new class of Company Unit, Class F Units, as consideration to the contributing members of AAM. The contributing members of AAM served as the general partner of the Partnership. With respect to distributions other than to the holders of the Class G Units, the Class F Units have subordinated payment and liquidity preference to the Class E Units (which were subsequently cancelled) but are senior in payment and liquidity preference, where applicable, to the Class A, B, C, and D Units of the Partnership. The Class F Units paid in quarterly installments an annual dividend of 8.25% of the preliminary face amount of $53,698,000 (of which half were subsequently redeemed). The preliminary pricing was based upon trading multiples of comparably sized publicly traded healthcare REITs. The ultimate Class F Unit valuation is subject to a true-up formula at the time of a Liquidity Event, as defined in the Partnership Agreement.

For accounting purposes, prior to the Merger, AAM had not been consolidated by the Company, nor had any value been ascribed to the Class F Units issued due to the ability of the Class E Unitholders prior to the Merger to unwind the acquisition as described below. Such action was outside the control of the Company, and accordingly, the acquisition is not viewed as having been consummated. The dividends earned by the Class F Unitholders were reflected as a component of management fees as described above. Prior to the Merger, the fee for management services to the Company was equal to the dividend earned on the Class F Unit.

Under certain circumstances, the Partnership Agreement did permit the Class E Unitholders to unwind this transaction and required the Company to redeem the Class F Units by returning to the affiliates all membership interests in AAM. On September 17, 2010, the Company settled the investment with JER Aviv Acquisition, LLC (JER), the sole Class E Unitholder, and cancelled all outstanding Class E Units. For accounting purposes, this treatment triggered the retroactive consolidation of AAM by the Company.

The original and follow-on investments of Class E unitholders were made subject to the Unit Purchase Agreement and related documents (UPA) between the Company and JER dated May 26, 2006. The UPA did not give either party the right to settle the investment prior to May 26, 2011. However, the UPA did have an economic arrangement as to how either party could settle the arrangement on or after that date. This economic construct guided the discussions and negotiations of settlement. The UPA allowed the Company to call the E Units and warrants anytime after May 26, 2011 as long as it provided JER with a 15% IRR from date of inception. The IRR would be calculated factoring interim distributions as well as exit payments. The units were settled for $92,001,451 contemporaneous with the Merger. A portion of the settlement related to outstanding warrants held by JER and originally issued in connection with the E units issuance.

Coincident with the Merger, 50% of the Class F Unit was purchased and settled by the Company for $23,602,649 and is reported as a component of distributions to partners and accretion on Class E Preferred Units in the consolidated statements of changes in equity. The remaining Class F Units will pay in quarterly installments an annual dividend of 9.38% of the face amount of $23,602,649.

11. Derivatives

During the periods presented, the Company was party to various interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the original debt agreements.

At September 30, 2011, the Company is party to two interest rate swaps, with identical terms for $100 million each. They were purchased to fix the variable interest rate on the denoted notional amount under the Mortgage which was obtained in September, 2010, and qualify for hedge accounting. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)


Total notional amount		$200,000,000
Fixed rates		6.49% (1.99% effective swap base rate plus 4.5% spread per credit agreement)
Floor rate		1.25%
Effective date		November 9, 2010
Termination date		September 17, 2015
Asset balance at September 30, 2011 (included in other assets)		$—
Asset balance at December 31, 2010 (included in other assets)		$4,094,432
Liability balance at September 30, 2011 (included in other liabilities)		$(3,069,611)
Liability balance at December 31, 2010 (included in other liabilities)		$—

The fair value of each interest rate swap agreement may increase or decrease due to changes in market conditions but will ultimately decrease to zero over the term of each respective agreement.

For the three and nine months ended September 30, 2011 and 2010, the Company recognized $0, $0, $489,312 and $2,931,309 of net income, respectively, in the consolidated statements of operations related to the change in the fair value of these interest rate swap agreements, where the Company did not elect to apply hedge accounting. Such instruments that did not elect to apply hedge accounting were settled at the Merger date.

The following table provides the Company’s derivative assets and liabilities carried at fair value as measured on a recurring basis as of September 30, 2011 (dollars in thousands):


	Total Carrying Value at September 30, 2011			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Derivative assets	$	—		$	—	$	—		$	—
Derivative liabilities		(3,069	)		—		(3,069	)		—

	$	(3,069	)	$	—	$	(3,069	)	$	—

The Company’s derivative assets and liabilities include interest rate swaps that effectively convert a portion of the Company’s variable rate debt to fixed rate debt. The derivative positions are valued using models developed by the respective counterparty that use as their basis readily observable market parameters (such as forward yield curves) and are classified within Level 2 of the valuation hierarchy. The Company considers its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives.

12. Commitments and Contingencies

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

The Company has a contractual arrangement with a tenant to reimburse quality assurance fees levied by the California Department of Health Care Services from August 1, 2005 through July 31, 2008. The Company is obligated to reimburse the fees to the tenant if and when the state withholds these fees from the tenant’s Medi-Cal reimbursements associated with 5 facilities that were formerly leased to Trinity Health Systems. The total possible obligation for these fees is approximately $1.7 million, of which approximately $1.3 million has been paid to date. For the three and nine months ended September 30, 2011, and 2010, the Company’s indemnity expense for these fees was $0.2 million, $0.3 million, $0.3 million and $1.0 million, respectively, which equaled the actual amount paid during the period, and are included as a component of general and administrative expense in the consolidated statements of operations.

Judicial proceedings seeking declaratory relief for these fees are in process which if successful would provide for recovery of such amounts from the State of California. The Company has certain rights to seek relief against Trinity Health Systems for monies paid out under the indemnity claim; however, it is uncertain whether the Company will be successful in receiving any amounts from Trinity.

During 2011, the Company entered into a contractual arrangement with a tenant in one of its facilities to reimburse any liabilities, obligations or claims of any kind or nature resulting from the actions of the former tenant in such facility, Brighten Health Care Group. The Company is obligated to reimburse the fees to the tenant if and when the tenant incurs such expenses associated with certain Indemnified Events, as defined therein. The total possible obligation for these fees is estimated to be $2.0 million, of which approximately $0.5 million has been paid to date. The $2.0 million was accrued and included as a component of general and administrative expense in the consolidated statements of operations for the three and nine months ended September 30, 2011.

In the normal course of business, the Company is involved in legal actions arising from the ownership of its property. In management’s opinion, the liabilities, if any, that may ultimately result from such legal actions are not expected to have a material adverse effect on the financial position, operations, or liquidity of the Company.

13. Concentration of Credit Risk

As of September 30, 2011, the Company’s portfolio of investments consisted of 200 healthcare facilities, located in 25 states and operated by 32 third party operators. At September 30, 2011, approximately 55.3% (measured as a percentage of total assets) were leased by five private operators: Evergreen Healthcare (14.1%), Daybreak Healthcare (12.9%), Sun Mar Healthcare (9.6%), Saber Healthcare (9.5%), and Benchmark Healthcare (9.2%). No other operator represents more than 7.9% of our total assets. The five states in which the Company had its highest concentration of total assets were California (19.5%), Texas (17.0%), Missouri (10.0%), Arkansas (8.3%), and New Mexico (6.1%) at September 30, 2011.

For the nine months ended September 30, 2011, the Company’s rental income from operations totaled approximately $64.8 million, of which approximately $8.9 million was from Evergreen Healthcare (13.7%), $7.6 million was from Daybreak Venture (11.7%), $7.3 million was from Sun Mar Healthcare (11.3%), $6.9 million was from Saber Healthcare (10.7%), and $5.3 million was from Cathedral Rock (8.1%). No other operator generated more than 6.5% of the Company’s rental income from operations for the nine months ended September 30, 2011.

14. Subsequent Events

On October 28, 2011, the REIT received a contribution of $30,000,000 from its stockholders which was further contributed to the Partnership.

On October 31, 2011, Aviv Financing II entered into a promissory note as the lender with an unrelated third party for a principal sum of $11,874,013, due to mature on February 28, 2013. At closing, Aviv Financing II funded $3,186,145 of the note with the remainder to be drawn over the course of the note.

On November 1, 2011, Aviv Financing I acquired five properties in Kansas from an unrelated third party for a purchase price of $10,800,000. The Company financed the purchase through cash and borrowings of $7,560,000 under the Acquisition Credit Line.

AVIV REIT, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

On November 1, 2011, Aviv Financing I acquired a property in Oklahoma from an unrelated third party for a purchase price of $3,300,000. The Company financed the purchase through cash and borrowings of $1,940,000 under the Acquisition Credit Line.

On November 1, 2011, Aviv Financing I disposed of 3 land parcels in Massachusetts in three separate transactions to unrelated third parties for a total selling price of $1,360,000 and will result in a gain that will be recognized in the fourth quarter.

On November 1, 2011, Aviv Financing I acquired 7 properties in Ohio and Pennsylvania from an unrelated third party for a purchase price of $50,143,000. The Company financed the purchase through cash and borrowings of $37,340,000 under the Acquisition Credit Line.

On November 1, 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of $6,657,000. The Company financed the purchase through cash.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited)


	September 30,			December 31,
	2011			2010
Assets
Cash and cash equivalents	$	4,995,185		$	13,028,474
Deferred rent receivable		28,873,295			30,660,773
Tenant receivables, net		6,090,209			1,168,842
Rental properties and financing leases, at cost:
Land		90,882,968			76,466,020
Buildings and improvements		705,696,951			615,806,273
Assets under direct financing leases		10,881,228			10,777,184

		807,461,147			703,049,477
Less accumulated depreciation		(91,252,681	)		(75,948,944	)

Net rental properties		716,208,466			627,100,533
Deferred finance costs, net		13,648,381			9,957,636
Loan receivables, net		30,868,334			36,610,638
Other assets		5,629,414			12,872,323

Total assets	$	806,313,284		$	731,399,219

Liabilities and equity
Accounts payable and accrued expenses	$	10,090,892		$	6,012,809
Tenant security and escrow deposits		14,218,676			13,658,384
Other liabilities		30,315,868			25,996,492
Mortgage and other notes payable		525,486,808			440,575,916

Total liabilities		580,112,244			486,243,601
Equity:
Partners’ equity		229,270,651			241,061,186
Accumulated other comprehensive (loss) income		(3,069,611	)		4,094,432

Total equity		226,201,040			245,155,618

Total liabilities and equity	$	806,313,284		$	731,399,219

See accompanying notes to consolidated financial statements.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Revenues
Rental income	$	20,979,359		$	21,354,972		$	64,782,196		$	63,776,959
Tenant recoveries		1,800,900			1,640,285			5,325,960			4,851,521
Interest on loans to lessees—capital expenditures		266,506			183,613			957,608			909,186
Interest on loans to lessees—working capital and capital lease		970,316			1,144,301			2,960,338			2,937,698

Total revenues		24,017,081			24,323,171			74,026,102			72,475,364

Expenses
Rent and other operating expenses		228,499			199,500			621,304			484,476
General and administrative		5,974,461			2,336,310			12,986,000			6,445,748
Real estate taxes		1,771,520			1,558,495			5,473,975			4,870,994
Depreciation		5,322,918			4,451,210			15,303,737			13,248,400
Loss on impairment		858,916			96,000			858,916			96,000

Total expenses		14,156,314			8,641,515			35,243,932			25,145,618

Operating income		9,860,767			15,681,656			38,782,170			47,329,746

Other income and expenses:
Interest and other income		7,276			(14,116	)		840,144			41,816
Interest expense		(9,311,128	)		(5,211,327	)		(26,226,779	)		(16,123,723	)
Change in fair value of derivatives		—			489,312			—			2,931,309
Amortization of deferred financing costs		(667,406	)		(194,324	)		(1,996,845	)		(472,914	)
Earnout accretion		(100,088	)		—			(166,814	)		—
Gain on sale of assets		—			581,734			—			581,734
Loss on extinguishment of debt		—			(2,285,028	)		(3,806,513	)		(2,285,028	)

Total other income and expenses		(10,071,346	)		(6,633,749	)		(31,356,807	)		(15,326,806	)

Net (loss) income		(210,579	)		9,047,907			7,425,363			32,002,940
Distributions and accretion on Class E Preferred Units		—			(9,353,806	)		—			(17,371,893	)
Net income allocable to noncontrolling interests		—			(84,773	)		—			(241,622	)

Net income allocable to common units	$	(210,579	)	$	(390,672	)	$	7,425,363		$	14,389,425

Net (loss) income allocable to common units	$	(210,579	)				$	7,425,363
Unrealized loss on derivative instruments		(4,086,047	)					(7,164,043	)

Total comprehensive (loss) income allocable to common units	$	(4,296,626	)				$	261,320

See accompanying notes to consolidated financial statements.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Consolidated Statement of Changes in Equity

Nine Months Ended September 30, 2011 (unaudited)


	Partners’ Equity			Accumulated Other Comprehensive Income (Loss)			Total Equity
Balance at January 1, 2011	$	241,061,186		$	4,094,432		$	245,155,618
Non-cash stock-based compensation		1,598,715			—			1,598,715
Distributions to partners		(31,234,370	)		—			(31,234,370	)
Capital contributions		10,419,757			—			10,419,757
Unrealized loss on derivative instruments		—			(7,164,043	)		(7,164,043	)
Net income		7,425,363			—			7,425,363

Balance at September 30, 2011	$	229,270,651		$	(3,069,611	)	$	226,201,040

See accompanying notes to consolidated financial statements.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited)


	Nine Months Ended September 30,
	2011			2010
Operating activities
Net income	$	7,425,363		$	32,002,940
Adjustments to reconcile net income to net cash provided byoperating activities:
Depreciation		15,303,737			13,248,400
Amortization		1,996,845			472,914
Change in fair value of derivatives		—			(2,931,309	)
Deferred rental loss (income), net		1,586,497			(2,600,415	)
Rental income from intangible amortization, net		(1,044,431	)		(3,318,913	)
Non-cash stock (unit)-based compensation		1,598,715			304,500
Non-cash loss on extinguishment of debt		3,806,513			1,437,233
Gain on sale of assets		—			(581,734	)
Loss on impairment of assets		858,916			96,000
Reserve for uncollectible loan receivables		1,250,113			—
Accretion of earn-out provision for previously acquired rental properties		166,814			—
Changes in assets and liabilities:
Due from related parties		—			(4,984,190	)
Tenant receivables		(6,685,920	)		557,018
Other assets		2,070,268			(324,958	)
Accounts payable and accrued expenses		95,433			(1,081,289	)
Tenant security deposits and other liabilities		1,780,161			39,809

Net cash provided by operating activities		30,209,024			32,336,006

Investing activities
Purchase of rental properties		(80,719,101	)		(8,380,000	)
Sale of rental properties		—			3,988,927
Capital improvements and other developments		(17,300,401	)		(5,863,863	)
Payment of earn-out provision for previously acquired rental properties		—			(9,600,731	)
Loan receivables received from (funded to) others, net		6,256,744			(5,637,247	)

Net cash used in investing activities		(91,762,758	)		(25,492,914	)

Financing activities
Borrowings of debt		328,802,912			405,000,000
Repayment of debt		(243,892,020	)		(480,309,036	)
Payment of financing costs		(9,429,792	)		(10,405,360	)
Payment for swap termination		—			(3,380,160	)
Capital contributions		10,419,757			223,772,055
Redemption of Class E Preferred Units		—			(92,001,451	)
Redemption of Class F Units		—			(23,602,649	)
Cash distributions to partners		(32,380,412	)		(33,003,335	)

Net cash provided by (used in) financing activities		53,520,445			(13,929,936	)

Net decrease in cash and cash equivalents		(8,033,289	)		(7,086,844	)
Cash and cash equivalents:
Beginning of period		13,028,474			15,542,507

End of period	$	4,995,185		$	8,455,663


Supplemental cash flow information
Cash paid for interest	$	25,080,857		$	16,644,364

Supplemental disclosure of noncash activity
Accrued distributions payable to partners	$	10,193,730		$	3,106,549
Earn-out accrual and addition to rental properties	$	3,332,745		$	—
Write-off of deferred rent receivable	$	6,785,132		$	2,233,768
Write-off of in-place lease intangibles, net	$	35,536		$	1,956,499
Write-off of deferred financing costs, net	$	3,806,513		$	1,235,969
Write-off debt discount	$	—		$	202,307

See accompanying notes to consolidated financial statements.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

1. Description of Operations and Formation

Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and Subsidiaries (the Partnership) was formed in 2005 and directly or indirectly owned or leased 200 properties, principally skilled nursing facilities, across the United States at September 30, 2011. The Partnership generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for tenants to pay the Partnership an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the tenants. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of real estate properties. The Partnership manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting.

On September 17, 2010, the predecessor to the Partnership entered into an agreement (the Merger Agreement), by and among Aviv REIT, Inc. (the REIT), a Maryland corporation, Aviv Healthcare Merger Sub LP (Merger Sub), a Delaware limited partnership of which the REIT is the general partner, Aviv Healthcare Merger Sub Partner LLC, a Delaware limited liability company and a wholly owned subsidiary of the REIT, and the Partnership. Effective on such date, the REIT is the sole general partner of the Partnership. Pursuant to the Merger Agreement, the predecessor to the Partnership merged (the Merger) with and into Merger Sub, with Merger Sub continuing as the surviving entity with the identical name (the Surviving Partnership). Following the Merger, the REIT remains as the sole general partner of the Surviving Partnership and the Surviving Partnership, as the successor to the predecessor to the Partnership, became the general partner of the Operating Partnership.

All of the business, assets and operations will continue to be held by the Operating Partnership and its subsidiaries. The REIT’s equity interest in the Surviving Partnership will be linked to future investments in the REIT, such that future equity issuances by the REIT (pursuant to the Stockholders Agreement, the REIT’s management incentive plan or otherwise as agreed between the parties) will result in a corresponding increase in the REIT’s equity interest in the Surviving Partnership. The REIT is authorized to issue 2 million shares of common stock (par value $0.01) and 1,000 shares of preferred stock (par value $1,000). At September 30, 2011, there were 235,898 shares of common stock and 125 shares of preferred stock outstanding. An additional 26,380 shares of common stock were issued by the REIT on October 28, 2011 concurrent with a $30 million equity contribution by the REIT’s stockholders.

As a result of the common control of the REIT (which was newly formed) and the predecessor to the Partnership, the Merger, for accounting purposes, did not result in any adjustment to the historical carrying value of the assets or liabilities of the Partnership. The REIT was funded in September 2010 with approximately $235 million from its stockholders, and such amounts, net of costs, was contributed to the Partnership in September 2010 in exchange for Class G Units in the Partnership. An additional $10 million was contributed by the REIT’s stockholders on January 25, 2011. As of September 30, 2011, the REIT owned 54.4% of the Partnership. On October 28, 2011, the REIT’s stockholders contributed $30 million to the REIT, which was further contributed to the Partnership, increasing the REIT ownership of the Partnership to 57.01%.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

2. Summary of Significant Accounting Policies

Estimates

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Partnership, the Surviving Partnership, the Operating Partnership, and all controlled subsidiaries. The Partnership considers itself to control an entity if it is the majority owner of and has voting control over such entity or the power to control a variable interest entity. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the consolidated statements of operations, and such parties’ portion of the net equity in such subsidiaries is reported on the consolidated balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation.

Quarterly Reporting

The accompanying unaudited financial statements and notes of the Partnership as of September 30, 2011 and for the three and nine months ended September 30, 2011 and 2010 have been prepared in accordance with GAAP for interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under GAAP have been condensed or omitted pursuant to such rules. In the opinion of management, all adjustments considered necessary for a fair presentation of the Partnership’s balance sheets, statements of operations, statement of changes in equity, and statements of cash flows have been included and are of a normal and recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the Partnership for the years ended December 31, 2010, 2009, and 2008. The consolidated statements of operations and cash flows for the three and nine months ended September 30, 2011 and 2010 are not necessarily indicative of full year results.

Rental Properties

The Partnership periodically assesses the carrying value of rental properties and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the rental properties will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the rental properties and related intangibles to their estimated fair value. The estimated fair value of the Partnership’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis. As part of the impairment evaluation during 2011, a building in Medford, MA was impaired for $858,916 to reflect the difference between the book value and the estimated selling price less costs to dispose (Level 3).

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

Revenue Recognition

Below is a summary of the components of rental income for the respective periods:


	Three Months Ended September 30,					Nine Months Ended September 30,
	2011			2010		2011			2010
Cash rental income	$	22,541,964		$	18,876,220	$	65,324,262		$	57,857,631
Deferred rental (loss) income		(1,882,643	)		1,423,137		(1,586,497	)		2,600,415
Rental income from intangible amortization		320,038			1,055,615		1,044,431			3,318,913

Total rental income	$	20,979,359		$	21,354,972	$	64,782,196		$	63,776,959

Lease Accounting

The Partnership, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statement of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as rental properties in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Partnership’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease. Such accretion was $33,832, $104,044, $35,100, and $107,614 for the three and nine months ended September 30, 2011 and 2010, respectively.

All of the Partnership’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

Loan Receivables

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

receivable reserves amounted to $2,000,113 and $750,000, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates.

Stock-Based Compensation

The Partnership follows ASC 718, Stock Compensation (ASC 718), which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated statements of operations based on their grant date fair values. On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction. A pro-rata allocation of non-cash stock-based compensation expense is made to the Partnership for awards granted under the Plan. The Plan’s non-cash stock-based compensation expense by the Partnership through September 30, 2011 is summarized in Footnote 9.

Fair Value of Financial Instruments

•

Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or;

•

Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The Partnership’s interest rate swaps are valued using models developed internally by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy.

Cash and cash equivalents and derivative financial instruments are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Partnership’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Partnership had outstanding mortgage and other notes payable obligations with a carrying value of approximately $525.5 million and $440.6 million as of September 30, 2011 and December 31, 2010, respectively. The fair values of debt as of September 30, 2011 was $502.2 million and as of December 31, 2010 approximates its carrying value based upon interest rates available to the Partnership on similar borrowings (Level 3). Management estimates the fair value of its loan receivables using a discounted cash flow analysis based upon the Partnership’s current interest rates for loan receivables with similar maturities and collateral securing the indebtedness. The Partnership had outstanding loan receivables with a carrying value of $30.9 million and $36.6 million as of September 30, 2011 and December 31, 2010, respectively. The fair values of loan receivables as of September 30, 2011 and as of December 31, 2010 approximate its carrying value based upon interest rates available to the Partnership on similar borrowings.

Derivative Instruments

The Partnership has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Partnership’s derivative instruments are recorded in the consolidated statements of operations if the derivative does not qualify for or the Partnership does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statement of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income. All of the changes in the fair market values of our derivative instruments are recorded in the consolidated statements of operations for our interest rate swaps that were terminated in September 2010. In November 2010, we entered into two interest rate swaps and account for changes in fair value of such hedges through accumulated other comprehensive (loss) income in equity in our financial statements via hedge accounting.

Income Taxes

As a limited partnership, the consolidated operating results are included in the income tax returns of the individual partners. Accordingly, the Partnership does not provide for federal income taxes. State income taxes were not significant in any of the periods presented. No uncertain income tax positions exist as of September 30, 2011 or December 31, 2010.

Business Combinations

The Partnership applies ASC 805, Business Combinations (ASC 805), in determining how to account for and identify business combinations while allocating fair value to tangible and identified intangible assets acquired and liabilities assumed using market comparables and historical operating results (Level 3). Acquisition related costs are expensed as incurred. Prior to the Merger on September 17, 2010, Aviv Asset Management, L.L.C. (AAM) was a non-consolidated management company to the Partnership based on the application of appropriate accounting guidance (as discussed in Footnote 10). Upon the Merger, AAM became a consolidated entity of the Partnership and is presented as such for all periods included herein with all periods shown at historical cost (carryover basis with no adjustments to fair value). This treatment is in accordance with ASC 805 due to the fact that AAM was under common control prior and subsequent to the Merger.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Partnership’s consolidated financial position or results of operations.

3. Rental Property Activity

The Partnership had the following rental property activity during the nine months ended September 30, 2011 as described below:

•

In January 2011, Aviv Financing I acquired a property in Kansas from an unrelated third party for a purchase price of $3,045,000. The Partnership financed this purchase through cash and borrowings of $2,131,000 under the Acquisition Credit Line (see Footnote 7).

•

In March 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of approximately $2,200,000. The Partnership financed this purchase through cash.

•

In March 2011, Aviv Financing II acquired a property in Ohio from an unrelated third party for a purchase price of approximately $9,581,000. The Partnership financed this purchase through cash.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

•

In March 2011, Aviv Financing II acquired a property in Florida from an unrelated third party for a purchase price of approximately $10,000,000. The Partnership financed this purchase through borrowings of $10,200,000 under the Revolver (see Footnote 7).

•

In April 2011, Aviv Financing II acquired three properties in Ohio from an unrelated third party for a purchase price of $9,250,000. The Partnership financed this purchase through cash.

•

In April 2011, Aviv Financing II acquired a property in Kansas from an unrelated third party for a purchase price of $1,300,000. The Partnership financed this purchase through cash.

•

In April 2011, Aviv Financing II acquired a property in Texas from an unrelated third party for a purchase price of $2,093,000. The Partnership financed this purchase through cash.

•

In April 2011, Aviv Financing II acquired three properties in Texas from an unrelated third party for a purchase price of $8,707,000. The Partnership financed this purchase through cash.

•

In May 2011, Aviv Financing II acquired three properties in Kansas from an unrelated third party for a purchase price of $2,273,000. The Partnership financed this purchase through cash.

•

In May 2011, Aviv Financing II acquired a property in Missouri from an unrelated third party for a purchase price of $5,470,000. The Partnership financed this purchase through cash.

•

In May 2011, Aviv Financing II acquired a property in Connecticut from an unrelated third party for a purchase price of $12,000,000. In addition, as part of this acquisition, the Partnership recognized an approximate $3,333,000 addition to the purchase price as per the guidance within ASC 805 as it relates to an earn-out provision defined at closing (Level 3). The Partnership financed this purchase through cash.

•

In August 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of $6,100,000. The Partnership financed this purchase through borrowings under the Revolver (see Footnote 7).

•

In August 2011, Aviv Financing II acquired a property in Connecticut from an unrelated third party for a purchase price of $5,500,000. The Partnership financed this purchase through borrowings under the Revolver (see Footnote 7).

•

In September 2011, Aviv Financing I acquired a property in Ohio from an unrelated third party for a purchase price of $3,200,000. The Partnership financed this purchase through borrowings under the Revolver (see Footnote 7).

Related to the above business combinations, the Partnership incurred $984,000 of acquisition costs that are expensed in general and administrative expenses in the consolidated statements of operations. In accordance with ASC 805, the Partnership allocated the approximate net purchase price paid for these properties acquired in 2011 as follows:


Land	$	13,288,000
Buildings and improvements		67,431,000

Borrowings and available cash	$	80,719,000

The Partnership considers renewals on below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Partnership evaluates whether the stated renewal rate is below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the tenant, and the number of years until potential renewal option exercise. If renewal is considered probable

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.

4. Loan Receivables

The following summarizes the Partnership’s loan receivables at:


	September 30, 2011			December 31, 2010
Beginning balance, January 1, 2011 and 2010, respectively	$	36,610,638		$	28,970,129
New capital improvement loans issued		765,463			1,415,579
Working capital and other loans issued		6,846,377			14,705,259
Reserve for uncollectible loans		(1,250,113	)		(750,000	)
Loan write offs		(86,156	)		—
Loan amortization and repayments		(12,017,875	)		(7,730,329	)

	$	30,868,334		$	36,610,638

The Partnership’s reserve for uncollectible loan receivables balances at September 30, 2011 and December 31, 2010 was $2,000,113 and $750,000, respectively. The activity for the three and nine months ended September 30, 2011 consisted of additional reserves of $926,474 and $1,250,113, respectively.

During 2011 and 2010, the Partnership funded loans for both working capital and capital improvement purposes to various operators and tenants. All loans held by the Partnership accrue interest. The payments received from the operator or tenant cover both interest accrued as well as amortization of the principal balance due. Any payments received from the tenant or operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.

Interest income earned on loan receivables for the three and nine months ended September 30, 2011 and 2010 was $880,965, $2,853,722, $976,682 and $2,796,655, respectively.

5. Deferred Finance Costs

The following summarizes the Partnership’s deferred finance costs at:


	September 30, 2011			December 31, 2010
Gross amount	$	15,790,721		$	10,567,931
Accumulated amortization		(2,142,340	)		(610,295	)

Net	$	13,648,381		$	9,957,636

Amortization of deferred financing costs is reported in the amortization expense line item in the consolidated statements of operations.

During the three and nine months ended September 30, 2011, the Partnership wrote-off deferred financing costs of $0 and $4,271,312, respectively with $0 and $464,799 of accumulated amortization associated with the Mortgage (see Footnote 7) pay down for a net recognition as loss on extinguishment of debt of $0 and $3,806,513, respectively.

6. In-Place Lease Intangibles

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

The following summarizes the Partnership’s in-place lease intangibles classified as part of other assets or other liabilities at:


	September 30, 2011						December 31, 2010
	Assets			Liabilities			Assets			Liabilities
Gross amount	$	7,460,119		$	24,363,147		$	8,393,488		$	25,798,147
Accumulated amortization		(3,193,933	)		(14,737,331	)		(3,049,093	)		(14,049,691	)

	$	4,266,186		$	9,625,816		$	5,344,395		$	11,748,456

For both the three and nine months ended September 30, 2011, the Partnership wrote-off in-place lease intangible assets of $933,369 with accumulated amortization of $338,587, and in-place lease intangible liabilities of $1,435,000 with accumulated accretion of $875,603, for a net recognition of $35,385 in rental income from intangible amortization. These write-offs were in connection with the anticipated termination of leases that will be transitioned to new operators.

During the three and nine months ended September 30, 2010, the Partnership wrote-off in-place lease intangible assets of $265,000 and $2,943,000 with accumulated amortization of $215,020 and $1,531,253, and in-place lease intangible liabilities of $3,817,347 and $8,477,347 with accumulated accretion of $3,035,463 and $5,109,101, for a net recognition of $731,904 and $1,956,499 in rental income from intangible amortization, respectively. These write-offs were in connection with the anticipated termination of leases that were transitioned to new operators.

7. Mortgage and Other Notes Payable

The Partnership’s mortgage and other notes payable consisted of the following:


	September 30, 2011		December 31, 2010
Mortgage (interest rates of 5.75% on September 30, 2011 and December 31, 2010, respectively)	$	197,859,139	$	402,794,111
Acquisition Credit Line (interest rates of 5.75% on September 30, 2011 and December 31, 2010, respectively)		—		28,677,230
Construction loan (interest rates of 5.95% on September 30, 2011 and December 31, 2010, respectively)		2,295,066		1,312,339
Revolver (interest rate of 6.50% on September 30, 2011)		15,000,000		—
Acquisition loans (interest rates of 6.00% on September 30, 2011 and December 31, 2010, respectively)		7,712,418		7,792,236
Senior Notes (interest rate of 7.75% on September 30, 2011), inclusive of $2.6 million net premium balance		302,620,185		—

Total	$	525,486,808	$	440,575,916

Senior Notes

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011. A premium of $2.75 million was associated with the offering of the $100 million of Senior Notes on April 5, 2011. The premium will be amortized as an adjustment to the yield on the Senior Notes over their term. The Partnership used the proceeds, amongst other things, to pay down approximately $201.6 million on the Mortgage and the balance of $28.7 million on the Acquisition Credit Line.

Revolver

In conjunction with the Senior Notes issuance on February 4, 2011, the Partnership, under Aviv Financing IV, LLC, entered into a $25 million revolver with Bank of America (the Revolver). On each payment date, the Partnership pays interest only in arrears on any outstanding principal balance of the Revolver. The interest rate under the Partnership’s Revolver is generally based on LIBOR (subject to a floor of 1.0% and subject to the Partnership’s option to elect to use a prime base rate) plus a margin that is determined by the Partnership’s leverage ratio from time to time. As of September 30, 2011 the interest rates are based upon the base rate (3.25% at September 30, 2011) plus the applicable percentage based on the consolidated leverage ratio (3.25% at September 30, 2011). The base rate is the rate announced by Bank of America as the “prime rate”. Additionally, an unused fee equal to 0.5% per annum of the daily unused balance on the Revolver is due monthly. The Revolver commitment terminates in February 2014. The Revolver had an outstanding balance of $15,000,000 at September 30, 2011.

8. Partnership Equity and Incentive Program

Distributions to the Partnership’s partners are summarized as follows for the three months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011	$	1,683,430	$	809,605	$	1,599,295	$	—	$	—	$	553,761	$	5,547,638
2010	$	2,911,567	$	997,288	$	9,072,045	$	—	$	1,623,288	$	958,840	$	—

Distributions to the Partnership’s partners are summarized as follows for the nine months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011	$	5,050,290	$	2,702,588	$	4,823,658	$	—	$	—	$	1,661,283	$	16,996,392
2010	$	9,692,937	$	2,894,457	$	11,917,798	$	—	$	5,342,466	$	3,155,677	$	—

Weighted-average Units outstanding are summarized as follows for the three months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011		13,467,223		4,523,145		2		8,050		—		2,684,900		236,022
2010		13,467,223		4,523,145		2		7,250		6,440,260		5,241,948		—

Weighted-average Units outstanding are summarized as follows for the nine months ended September 30:


	Class A		Class B		Class C		Class D		Class E		Class F		Class G
2011		13,467,223		4,523,145		2		8,050		—		2,684,900		235,207
2010		13,467,223		4,523,145		2		7,403		7,142,888		4,990,412		—

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

The Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards can be settled in Class C Units or cash at the Partnership’s discretion at the settlement date of December 31, 2012. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for the three and nine months ended September 30, 2011 and 2010 was approximately $101,500, $304,500, $101,500 and $304,500, respectively.

The Partnership’s equity balance that is presented on the consolidated balance sheets is split between the general partner and limited partners in the amounts of $219,557,324 and $9,713,327 at September 30, 2011, respectively. The Partnership’s equity balance that is presented on the consolidated balance sheets is split between the general partner and limited partners in the amounts of $221,578,430 and $19,482,756 at December 31, 2010, respectively.

9. Option Awards

On September 17, 2010, the Company adopted a 2010 Management Incentive Plan (the Plan) as part of the Merger transaction.

The following table represents the time based option awards activity for the nine months ended September 30, 2011.


	Nine months ended September 30, 2011
Outstanding at January 1, 2011		21,866
Granted		456
Exercised		—
Cancelled/Forfeited		—

Outstanding at March 31, 2011		22,322
Granted		—
Exercised		—
Cancelled/Forfeited		—

Outstanding at June 30, 2011		22,322
Granted		—
Exercised		—
Cancelled/Forfeited		—

Outstanding at September 30, 2011		22,322
Options exercisable at end of period		—

Weighted average fair value of options granted to date	$	109.37

Weighted average remaining contractual life (years)		8.97

The following table represents the time based option awards outstanding at September 30, 2011 as well as other Plan data:

Range of

Exercise Prices

Outstanding

Remaining Contractual
Life (Years)

Weighted Average

Exercise Price

$1,000 – $1,124

22,322

8.98

$1,004

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

The Partnership has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2011.


	2011 Grants
Dividend yield		9.16	%
Risk-free interest rate		2.72	%
Expected life		7.0 years
Estimated volatility		38.00	%
Weighted average exercise price	$	1,124.22
Weighted average fair value of options granted (per option)	$	149.09

The Partnership recorded non-cash compensation expenses of $329,889 and $936,256 for the three and nine months ended September 30, 2011, related to the time based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations, respectively.


For the period ended December 31,	Options
2011	$	168,963
2012		575,013
2013		304,499
2014		119,078
2015		53

Total	$	1,167,606

10. Related Parties

Related party receivables and payables represent amounts due from/to various affiliates of the Partnership, including advances to members of the Partnership, amounts due to certain acquired companies and limited liability companies for transactions occurring prior to the formation of the Partnership, and various advances to entities controlled by affiliates of the Partnership’s management. An officer of the Company received a loan of $311,748, which has been paid off in full as of September 30, 2011.

The Partnership had entered into a management agreement, as amended, effective April 1, 2005, with AAM, an entity affiliated by common ownership. Under the management agreement, AAM had been granted the exclusive right to oversee the portfolio of the Partnership, providing, among other administrative services, accounting and all required financial services; legal administration and regulatory compliance; investor, tenant, and lender relationship services; and transactional support to the Partnership. Except as otherwise provided in the Partnership Agreement, all management powers of the business and affairs of the Partnership were exclusively vested in the General Partner. The annual fee for such services equaled six-tenths of one percent (0.6%) of the aggregate fair market value of the properties as determined by the Partnership and AAM annually. This fee arrangement was amended as discussed below. In addition, the Partnership reimbursed AAM for all reasonable and necessary out-of-pocket expenses incurred in AAM’s conduct of its business, including, but not limited to, travel, legal, appraisal, and brokerage fees, fees and expenses incurred in connection with the acquisition, disposition, or refinancing of any property, and reimbursement of compensation and benefits of the officers and employees of AAM. This agreement was terminated on September 17, 2010 when the Merger occurred, effectively consolidating AAM into the Partnership, and eliminating the necessity for reimbursement.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

On October 16, 2007, the Partnership legally acquired AAM through a Manager Contribution and Exchange Agreement dated October 16, 2007 (the Contribution Agreement). As stipulated in the Contribution Agreement and the Second Amended and Restated Agreement of Limited Partnership on October 16, 2007 (Partnership Agreement), the Partnership issued a new class of Partnership Unit, Class F Units, as consideration to the contributing members of AAM. The contributing members of AAM served as the general partner of the Partnership. With respect to distributions other than to the holders of the Class G Units, the Class F Units have subordinated payment and liquidity preference to the Class E Units (which were subsequently cancelled) but are senior in payment and liquidity preference, where applicable, to the Class A, B, C, and D Units of the Partnership. The Class F Units paid in quarterly installments an annual dividend of 8.25% of the preliminary face amount of $53,698,000 (of which half were subsequently redeemed). The preliminary pricing was based upon trading multiples of comparably sized publicly traded healthcare REITs. The ultimate Class F Unit valuation is subject to a true-up formula at the time of a Liquidity Event, as defined in the Partnership Agreement.

For accounting purposes, prior to the Merger, AAM had not been consolidated by the Partnership, nor had any value been ascribed to the Class F Units issued due to the ability of the Class E Unitholders prior to the Merger to unwind the acquisition as described below. Such action was outside the control of the Partnership, and accordingly, the acquisition is not viewed as having been consummated. The dividends earned by the Class F Unitholders were reflected as a component of management fees as described above. Prior to the Merger, the fee for management services to the Partnership was equal to the dividend earned on the Class F Unit.

Under certain circumstances, the Partnership Agreement did permit the Class E Unitholders to unwind this transaction and required the Partnership to redeem the Class F Units by returning to the affiliates all membership interests in AAM. On September 17, 2010, the Partnership settled the investment with JER Aviv Acquisition, LLC (JER), the sole Class E Unitholder, and cancelled all outstanding Class E Units. For accounting purposes, this treatment triggered the retroactive consolidation of AAM by the Partnership.

The original and follow-on investments of Class E unitholders were made subject to the Unit Purchase Agreement and related documents (UPA) between the Partnership and JER dated May 26, 2006. The UPA did not give either party the right to settle the investment prior to May 26, 2011. However, the UPA did have an economic arrangement as to how either party could settle the arrangement on or after that date. This economic construct guided the discussions and negotiations of settlement. The UPA allowed the Partnership to call the E Units and warrants anytime after May 26, 2011 as long as it provided JER with a 15% IRR from date of inception. The IRR would be calculated factoring interim distributions as well as exit payments. The units were settled for $92,001,451 contemporaneous with the Merger. A portion of the settlement related to outstanding warrants held by JER and originally issued in connection with the E units issuance.

Coincident with the Merger, 50% of the Class F Unit was purchased and settled by the Partnership for $23,602,649 and is reported as a component of distributions to partners and accretion on Class E Preferred Units in the consolidated statements of changes in equity. The remaining Class F Units will pay in quarterly installments an annual dividend of 9.38% of the face amount of $23,602,649.

11. Derivatives

During the periods presented, the Partnership was party to various interest rate swaps, which were purchased to fix the variable interest rate on the denoted notional amount under the original debt agreements.

At September 30, 2011, the Partnership is party to two interest rate swaps, with identical terms for $100 million each. They were purchased to fix the variable interest rate on the denoted notional amount under the Mortgage which was obtained in September, 2010, and qualify for hedge accounting. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.


Total notional amount		$200,000,000
Fixed rates		6.49% (1.99% effective swap base rate plus 4.5% spread per credit agreement)

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)


Floor rate		1.25%
Effective date		November 9, 2010
Termination date		September 17, 2015
Asset balance at September 30, 2011 (included in other assets)		$—
Asset balance at December 31, 2010 (included in other assets)		$4,094,432
Liability balance at September 30, 2011 (included in other liabilities)		$(3,069,611)
Liability balance at December 31, 2010 (included in other liabilities)		$—

The fair value of each interest rate swap agreement may increase or decrease due to changes in market conditions but will ultimately decrease to zero over the term of each respective agreement.

For the three and nine months ended September 30, 2011 and 2010, the Partnership recognized $0, $0, $489,312 and $2,931,309 of net income, respectively, in the consolidated statements of operations related to the change in the fair value of these interest rate swap agreements, where the Partnership did not elect to apply hedge accounting. Such instruments that did not elect to apply hedge accounting were settled at the Merger date.

The following table provides the Partnership’s derivative assets and liabilities carried at fair value as measured on a recurring basis as of September 30, 2011 (dollars in thousands):


	Total Carrying Value at September 30, 2011			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Derivative assets	$	—		$	—	$	—		$	—
Derivative liabilities		(3,069	)		—		(3,069	)		—

	$	(3,069	)	$	—	$	(3,069	)	$	—

The Partnership’s derivative assets and liabilities include interest rate swaps that effectively convert a portion of the Partnership’s variable rate debt to fixed rate debt. The derivative positions are valued using models developed by the respective counterparty that use as their basis readily observable market parameters (such as forward yield curves) and are classified within Level 2 of the valuation hierarchy. The Partnership considers its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives.

12. Commitments and Contingencies

The Partnership has a contractual arrangement with a tenant to reimburse quality assurance fees levied by the California Department of Health Care Services from August 1, 2005 through July 31, 2008. The Partnership is obligated to reimburse the fees to the tenant if and when the state withholds these fees from the tenant’s Medi-Cal reimbursements associated with 5 facilities that were formerly leased to Trinity Health Systems. The total possible obligation for these fees is approximately $1.7 million, of which approximately $1.3 million has been paid to date. For the three and nine months ended September 30, 2011, and 2010, the Partnership’s indemnity expense for these fees was $0.2

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

million, $0.3 million, $0.3 million, and $1.0 million, respectively, which equaled the actual amount paid during the period, and are included as a component of general and administrative expense in the consolidated statements of operations.

Judicial proceedings seeking declaratory relief for these fees are in process which if successful would provide for recovery of such amounts from the State of California. The Partnership has certain rights to seek relief against Trinity Health Systems for monies paid out under the indemnity claim; however, it is uncertain whether the Partnership will be successful in receiving any amounts from Trinity.

During 2011, the Partnership entered into a contractual arrangement with a tenant in one of its facilities to reimburse any liabilities, obligations or claims of any kind or nature resulting from the actions of the former tenant in such facility, Brighten Health Care Group. The Partnership is obligated to reimburse the fees to the tenant if and when the tenant incurs such expenses associated with certain Indemnified Events, as defined therein. The total possible obligation for these fees is estimated to be $2.0 million, of which approximately $0.5 million has been paid to date. The $2.0 million was accrued and included as a component of general and administrative expense in the consolidated statements of operations for the three and nine months ended September 30, 2011.

In the normal course of business, the Partnership is involved in legal actions arising from the ownership of its property. In management’s opinion, the liabilities, if any, that may ultimately result from such legal actions are not expected to have a material adverse effect on the financial position, operations, or liquidity of the Partnership.

13. Concentration of Credit Risk

As of September 30, 2011, the Partnership’s portfolio of investments consisted of 200 healthcare facilities, located in 25 states and operated by 32 third party operators. At September 30, 2011, approximately 55.3% (measured as a percentage of total assets) were leased by five private operators: Evergreen Healthcare (14.1%), Daybreak Healthcare (12.9%), Sun Mar Healthcare (9.6%), Saber Healthcare (9.5%), and Benchmark Healthcare (9.2%). No other operator represents more than 7.9% of our total assets. The five states in which the Partnership had its highest concentration of total assets were California (19.5%), Texas (17.0%), Missouri (10.0%), Arkansas (8.3%), and New Mexico (6.1%) at September 30, 2011.

For the nine months ended September 30, 2011, the Partnership’s rental income from operations totaled approximately $64.8 million, of which approximately $8.9 million was from Evergreen Healthcare (13.7%), $7.6 million was from Daybreak Venture (11.7%), $7.3 million was from Sun Mar Healthcare (11.3%), $6.9 million was from Saber Healthcare (10.7%), and $5.3 million was from Cathedral Rock (8.1%). No other operator generated more than 6.5% of the Partnership’s rental income from operations for the nine months ended September 30, 2011.

14. Subsequent Events

On October 28, 2011, the REIT received a contribution of $30,000,000 from its stockholders which was further contributed to the Partnership.

On November 1, 2011, Aviv Financing I acquired five properties in Kansas from an unrelated third party for a purchase price of $10,800,000. The Partnership financed the purchase through cash and borrowings of $7,560,000 under the Acquisition Credit Line.

On November 1, 2011, Aviv Financing I acquired a property in Oklahoma from an unrelated third party for a purchase price of $3,300,000. The Partnership financed the purchase through cash and borrowings of $1,940,000 under the Acquisition Credit Line.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited) - (continued)

On November 1, 2011, Aviv Financing I acquired 7 properties in Ohio and Pennsylvania from an unrelated third party for a purchase price of $50,143,000. The Partnership financed the purchase through cash and borrowings of $37,340,000 under the Acquisition Credit Line.

On November 1, 2011, Aviv Financing II acquired a property in Pennsylvania from an unrelated third party for a purchase price of $6,657,000. The Partnership financed the purchase through cash.

15. Condensed Consolidating Information

The Company and certain of the Partnership’s direct and indirect wholly owned subsidiaries (the “Wholly Owned Subsidiary Guarantors”) fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to our Senior Notes issued in February 2011 and April 2011. Separate financial statements of the guarantors are not provided as the consolidating financial information contained herein provides a more meaningful disclosure to allow investors to determine the nature of the assets held by and the operations of the respective guarantor and non-guarantor subsidiaries. Other wholly owned subsidiaries (“Non-Guarantor Subsidiaries”) that were not included among the Guarantors were not obligated with respect to the Senior Notes. The Non-Guarantor Subsidiaries are subject to mortgages. The following summarizes our condensed consolidating information as of September 30, 2011 and December 31, 2010 and for the three and nine months ended September 30, 2011 and 2010:

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING BALANCE SHEET

As of September 30, 2011

(unaudited)


	Issuers		Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Cash and cash equivalents	$	5,271,415	$	(180,674	)	$	(95,556	)	$	—		$	4,995,185
Net rental properties		—		695,350,780			20,857,686			—			716,208,466
Deferred financing costs, net		8,052,697		5,578,415			17,269			—			13,648,381
Other		11,433,017		59,919,777			108,458			—			71,461,252
Investment in and due from related parties, net		519,873,869		(306,467,903	)		(9,024,554	)		(204,381,412	)		—

Total assets	$	544,630,998	$	454,200,395		$	11,863,303		$	(204,381,412	)	$	806,313,284

Liabilities and equity
Mortgage and other notes payable	$	302,620,185	$	212,859,139		$	10,007,484		$	—		$	525,486,808
Due to related parties		6,071,663		—			—			—			6,071,663
Tenant security and escrow deposits		25,000		13,993,509			200,167			—			14,218,676
Accounts payable and accrued expenses		3,779,263		5,382,260			929,369			—			10,090,892
Other liabilities		5,930,847		18,313,358			—			—			24,244,205

Total liabilities		318,426,958		250,548,266			11,137,020			—			580,112,244
Total equity		226,204,040		203,652,129			726,283			(204,381,412	)		226,201,040

Total liabilities and equity	$	544,630,998	$	454,200,395		$	11,863,303		$	(204,381,412	)	$	806,313,284

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2010

(unaudited)


	Issuers		Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Cash and cash equivalents	$	12,126,776	$	908,612		$	(6,914	)	$	—		$	13,028,474
Net rental properties		—		609,972,113			17,128,420			—			627,100,533
Deferred financing costs, net		100,000		9,834,291			23,345			—			9,957,636
Other		13,380,055		67,896,040			36,481			—			81,312,576
Investment in and due from related parties, net		232,906,755		(42,847,014	)		(6,964,810	)		(183,094,931	)		—

Total assets	$	258,513,586	$	645,764,042		$	10,216,522		$	(183,094,931	)	$	731,399,219

Liabilities and equity
Mortgage and other notes payable	$	—	$	431,471,341		$	9,104,575		$	—		$	440,575,916
Due to related parties		6,092,936		—			—			—			6,092,936
Tenant security and escrow deposits		—		13,422,705			235,679			—			13,658,384
Accounts payable and accrued expenses		1,431,564		4,102,506			478,739			—			6,012,809
Other liabilities		5,833,468		14,070,088			—			—			19,903,556

Total liabilities		13,357,968		463,066,640			9,818,993			—			486,243,601
Total equity		245,155,618		182,697,402			397,529			(183,094,931	)		245,155,618

Total liabilites and equity	$	258,513,586	$	645,764,042		$	10,216,522		$	(183,094,931	)	$	731,399,219

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Three Months Ended September 30, 2011

(unaudited)


	Issuers			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Rental income	$	—		$	20,633,075		$	346,284		$	—		$	20,979,359
Tenant recoveries		—			1,770,829			30,071			—			1,800,900
Interest on loans to lessees		436,193			800,629			—			—			1,236,822

Total revenues		436,193			23,204,533			376,355			—			24,017,081
Expenses
Rent and other operating expenses		39,958			188,541			—			—			228,499
General and administrative		2,960,242			3,013,419			800			—			5,974,461
Real estate taxes		—			1,741,449			30,071			—			1,771,520
Depreciation		—			5,205,742			117,176			—			5,322,918
Loss on impairment		—			858,916			—			—			858,916

Total expenses		3,000,200			11,008,067			148,047			—			14,156,314

Operating (loss) income		(2,564,007	)		12,196,466			228,308			—			9,860,767

Total other income and expenses		(5,952,062	)		(4,001,306	)		(117,978	)		—			(10,071,346	)

Net (loss) income		(8,516,069	)		8,195,160			110,330			—			(210,579	)

Equity in income (loss) of subsidiaries		8,305,490			—			—			(8,305,490	)		—

Net (loss) income allocable to common units	$	(210,579	)	$	8,195,160		$	110,330		$	(8,305,490	)	$	(210,579	)

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Nine Months Ended September 30, 2011

(unaudited)


	Issuers			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Rental income	$	—		$	63,743,341		$	1,038,855		$	—		$	64,782,196
Tenant recoveries		—			5,235,746			90,214			—			5,325,960
Interest on loans to lessees		1,058,317			2,859,629			—			—			3,917,946

Total revenues		1,058,317			71,838,716			1,129,069			—			74,026,102
Expenses
Rent and other operating expenses		120,526			500,778			—			—			621,304
General and administrative		6,235,686			6,746,687			3,627			—			12,986,000
Real estate taxes		—			5,383,762			90,213			—			5,473,975
Depreciation		—			14,952,208			351,529			—			15,303,737
Loss on impairment		—			858,916			—			—			858,916

Total expenses		6,356,212			28,442,351			445,369			—			35,243,932

Operating (loss) income		(5,297,895	)		43,396,365			683,700			—			38,782,170

Total other income and expenses		(14,421,675	)		(16,580,185	)		(354,947	)		—			(31,356,807	)

Net (loss) income		(19,719,570	)		26,816,180			328,753			—			7,425,363

Equity in income (loss) of subsidiaries		27,144,933			—			—			(27,144,933	)		—

Net (loss) income allocable to common units	$	7,425,363		$	26,816,180		$	328,753		$	(27,144,933	)	$	7,425,363

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Three Months Ended September 30, 2010

(unaudited)


	Issuers			Subsidiary Guarantors			Non- Guarantor Subsidiaries		Eliminations			Consolidated
Revenues
Rental income	$	—		$	21,269,273		$	85,699	$	—		$	21,354,972
Tenant recoveries		—			1,620,844			19,441		—			1,640,285
Interest on loans to lessees		448,264			879,650			—		—			1,327,914

Total revenues		448,264			23,769,767			105,140		—			24,323,171
Expenses
Rent and other operating expenses		—			199,500			—		—			199,500
General and administrative		538,258			1,793,684			4,368		—			2,336,310
Real estate taxes		—			1,539,054			19,441		—			1,558,495
Depreciation		—			4,416,056			35,154		—			4,451,210
Loss on impairment		—			96,000			—					96,000

Total expenses		538,258			8,044,294			58,963		—			8,641,515

Operating (loss) income		(89,994	)		15,725,473			46,177		—			15,681,656

Total other income and expenses		(98,938	)		(6,534,811	)		—		—			(6,633,749	)

Net (loss) income		(188,932	)		9,190,662			46,177		—			9,047,907

Distributions and accretion on Class E Preferred units		(9,353,806	)		—			—		—			(9,353,806	)
Net income attributable to noncontrolling interests		(84,773	)		—			—		—			(84,773	)
Equity in income (loss) of subsidiaries		9,236,839			—			—		(9,236,839	)		—

Net (loss) income allocable to common units	$	(390,672	)	$	9,190,662		$	46,177	$	(9,236,839	)	$	(390,672	)

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Nine Months Ended September 30, 2010

(unaudited)


	Issuers			Subsidiary Guarantors			Non- Guarantor Subsidiaries		Eliminations			Consolidated
Revenues
Rental income	$	—		$	63,374,715		$	402,244	$	—		$	63,776,959
Tenant recoveries		—			4,793,199			58,322		—			4,851,521
Interest on loans to lessees		1,146,486			2,700,398			—		—			3,846,884

Total revenues		1,146,486			70,868,312			460,566		—			72,475,364
Expenses
Rent and other operating expenses		—			484,476			—		—			484,476
General and administrative		1,641,708			4,798,973			5,067		—			6,445,748
Real estate taxes		—			4,812,672			58,322		—			4,870,994
Depreciation		—			13,143,298			105,102		—			13,248,400
Loss on impairment		—			96,000			—		—			96,000

Total expenses		1,641,708			23,335,419			168,491		—			25,145,618

Operating (loss) income		(495,222	)		47,532,893			292,075		—			47,329,746

Total other income and expenses		(302,212	)		(15,024,594	)		—		—			(15,326,806	)

Net (loss) income		(797,434	)		32,508,299			292,075		—			32,002,940

Distributions and accretion on Class E Preferred units		(17,371,893	)		—			—		—			(17,371,893	)
Net income attributable to noncontrolling interests		(241,622	)		—			—		—			(241,622	)
Equity in income (loss) of subsidiaries		32,800,374			—			—		(32,800,374	)		—

Net (loss) income allocable to common units	$	14,389,425		$	32,508,299		$	292,075	$	(32,800,374	)	$	14,389,425

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Nine Months Ended September 30, 2011

(unaudited)


	Issuers			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations		Consolidated
Net cash (used in) provided by operating activities	$	(280,891,669	)	$	308,940,822		$	2,159,871		$	—	$	30,209,024
Net cash provided by (used in) investing activities		1,906,008			(90,517,343	)		(3,151,423	)		—		(91,762,758	)
Financing activities
Borrowings of debt		302,620,184			25,200,000			982,728			—		328,802,912
Repayment of debt		—			(243,812,202	)		(79,818	)		—		(243,892,020	)
Payment of financing costs		(8,529,229	)		(900,563	)		—			—		(9,429,792	)
Capital contributions		10,419,757			—			—			—		10,419,757
Cost of raising capital		—			—			—			—		—
Cash distributions to partners		(32,380,412	)		—			—			—		(32,380,412	)

Net cash provided by (used in) financing activities		272,130,300			(219,512,765	)		902,910			—		53,520,445

Net decrease in cash and cash equivalents		(6,855,361	)		(1,089,286	)		(88,642	)		—		(8,033,289	)
Cash and cash equivalents:
Beginning of period		12,126,776			908,612			(6,914	)		—		13,028,474

End of period	$	5,271,415		$	(180,674	)	$	(95,556	)	$	—	$	4,995,185

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to the Consolidated Financial Statements - unaudited - (continued)

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Nine Months Ended September 30, 2010

(unaudited)


	Issuers			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations		Consolidated
Net cash (used in) provided by operating activities	$	(55,606,900	)	$	87,979,517		$	(36,611	)	$	—	$	32,336,006
Net cash used in investing activities		(2,054,813	)		(23,438,101	)		—			—		(25,492,914	)
Financing activities
Borrowings of debt		—			405,000,000			—			—		405,000,000
Repayment of debt		(12,000,000	)		(468,309,036	)		—			—		(480,309,036	)
Payment of financing costs		—			(10,405,360	)		—			—		(10,405,360	)
Payment for swap termination		—			(3,380,160	)		—			—		(3,380,160	)
Capital contributions		223,772,055			—			—			—		223,772,055
Redemption of Class E Preferred Units		(92,001,451	)		—			—			—		(92,001,451	)
Redemption of Class F Units		(23,602,649	)		—			—			—		(23,602,649	)
Cash distributions to partners		(29,847,658	)		(3,155,677	)		—			—		(33,003,335	)

Net cash provided by (used in) financing activities		66,320,297			(80,250,233	)		—			—		(13,929,936	)

Net increase (decrease) in cash and cash equivalents		8,658,584			(15,708,817	)		(36,611	)		—		(7,086,844	)
Cash and cash equivalents:
Beginning of period		256,598			15,285,909